Outcome of adenotonsillectomy for obstructive sleep apnea in obese and normal-weight children

Ron B Mitchell1, James Kelly

  • 1Division of Pediatric Otolaryngology, Department of Otolaryngology-Head and Neck Surgery, Saint Louis University School of Medicine, St Louis, MO 63104, USA. rmitch11@slu.edu

Insights

Obese children have more severe obstructive sleep apnea (OSA) than normal-weight children. Adenotonsillectomy improves OSA in both groups, but persistent obstructive sleep apnea remains more common in obese children.

Area of Science:

  • Pediatric Sleep Medicine
  • Otolaryngology
  • Obesity Research

Background:

  • Obstructive sleep apnea (OSA) is a common sleep disorder in children.
  • Obesity is a known risk factor for OSA, but its impact on severity and treatment outcomes in pediatric populations requires further investigation.

Purpose of the Study:

  • To compare the severity of obstructive sleep apnea (OSA) in obese versus normal-weight children.
  • To evaluate the effectiveness of adenotonsillectomy in improving respiratory parameters in obese and normal-weight children with OSA.

Main Methods:

  • Prospective controlled trial involving children aged 3 to 18 years.
  • Preoperative and postoperative polysomnography was conducted for all participants.
  • Comparison of apnea-hypopnea index (AHI) between obese and normal-weight groups.

Main Results:

  • Obese children exhibited a significantly higher median preoperative apnea-hypopnea index (AHI) (23.4) compared to normal-weight controls (17.1).
  • Following adenotonsillectomy, both groups showed a significant reduction in AHI, but persistent OSA was more prevalent in obese children (76%) than in controls (28%).
  • Postoperative AHI was 3.1 for obese children and 1.9 for normal-weight children.

Conclusions:

  • Obesity is associated with increased severity of obstructive sleep apnea in children.
  • Adenotonsillectomy significantly improves OSA in both obese and normal-weight children.
  • Obese children are at higher risk for persistent OSA after adenotonsillectomy, highlighting the need for continued monitoring and management strategies.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.